구글상위노출 | PBN백링크판매 | 홍보프로그램판매 |

FDA Joint Advisory Committee Votes in Favor of Perrigo’s Opill® Daily Oral Contraceptive for OTC Use

[ad_1]

DUBLIN, May 10, 2023 /PRNewswire/ — Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced today that the U.S. Food and Drug Administration’s (FDA) Nonprescription Drugs Advisory Committee (NDAC) and the…

[ad_2]

Source link

Leave a Reply

이메일 주소는 공개되지 않습니다. 필수 필드는 *로 표시됩니다